Patent · US Active

Fused bicyclic mTor inhibitors

US7923555B2 · kind B2 · utility

13Cited by
3References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2008
Grant dateApr 12, 2011
Priority date—
Expiry dateDec 2, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds represented by Formula (I)or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.